Show Notes
Part 1 of 4 of our series with Alex Telford, founder of Convoke.
In this episode of The Biotech Startups Podcast, Jon Chee sits down with Alex Telford, founder of Convoke, who raised $8.6 million to build the AI-native operating system for biopharma. Part one traces his path from an expat childhood across Switzerland, Germany, and Spain — shaped by international schools, disappearing friendships, and a New Scientist subscription — through biochemistry at Bristol and into a synthetic biology master's at UCL that promised biological engineering and delivered toggle switches.
Key Topics Covered:
- Expat Childhood and Comfort with Impermanence: Growing up in international schools where best friends disappeared with each relocation built a tolerance for instability that made leaving a stable consulting career feel manageable.
- Science as Self-Directed Curiosity: No scientists in the family — just New Scientist, National Geographic, and two teachers who steered him toward biochemistry.
- Choosing University on Personal, Not Academic, Grounds: Applied to Bristol because his mum had a friend there, York because his grandmother lived there. Got into Oxford. Went to Bristol.
- What Wet Lab Work Actually Feels Like: Three months of Western blots on red blood cell proteins — slow, hard to debug, and disconnected from application.
- Synthetic Biology's Gap Between Promise and Practice: The UCL master's offered biological robots and re-engineered supply chains. The actual work was genetic toggle switches that mutate within a few divisions.
Resources & Articles
- Why Some Biotech Startups Struggle to Scale: https://www.excedr.com/resources/why-some-biotech-startups-struggle-to-scale
- IB Diploma Programme: https://en.wikipedia.org/wiki/IB_Diploma_Programme
- MRC Laboratory of Molecular Biology — History: https://mrclmb.ac.uk/about/history/
- Genetic Circuits in Synthetic Biology: Broadening the Toolkit: https://www.frontiersin.org/journals/synthetic-biology/articles/10.3389/fsybi.2025.1548572/full
- Artificial Intelligence in Drug Discovery and Development: https://pmc.ncbi.nlm.nih.gov/articles/PMC7577280/
Organizations & People
- Convoke: https://www.convoke.bio/
- Dow Chemical: https://www.dow.com
- University of Bristol: https://www.bristol.ac.uk
- University College London (UCL): https://www.ucl.ac.uk
- Kleiner Perkins: https://www.kleinerperkins.com
- Dimension Capital: https://www.dimensioncap.com/
- Leigh Marie Braswell (Partner, Kleiner Perkins): https://www.linkedin.com/in/leigh-marie-braswell
- Nan Li (Managing Partner, Dimension Capital): https://www.linkedin.com/in/nanli
- Qasar Younis (CEO, Applied Intuition): https://www.linkedin.com/in/qasar




